Abstract
First clinical experience with 17- estradiol-eluting biodivYsio matrix LO stent to prevent restenosis in de-novo native coronary arteries: Six-month clinical outcomes and angiographic follow-up from the EASTER trial
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
